BIO-key International, Inc.
BKYI
$0.79
$0.0212.73%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 6.93M | 7.29M | 6.96M | 7.75M | 7.75M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 6.93M | 7.29M | 6.96M | 7.75M | 7.75M |
| Cost of Revenue | 1.29M | 2.95M | 3.96M | 5.30M | 6.32M |
| Gross Profit | 5.64M | 4.34M | 3.01M | 2.45M | 1.43M |
| SG&A Expenses | 7.19M | 7.51M | 7.68M | 7.88M | 8.03M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 10.94M | 12.76M | 13.82M | 15.33M | 16.58M |
| Operating Income | -4.01M | -5.47M | -6.85M | -7.58M | -8.83M |
| Income Before Tax | -4.32M | -5.57M | -6.66M | -7.48M | -8.66M |
| Income Tax Expenses | -23.00K | -276.80K | -277.00K | -134.00K | -134.00K |
| Earnings from Continuing Operations | -4.30 | -5.29 | -6.39 | -7.34 | -8.52 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -4.30M | -5.29M | -6.39M | -7.34M | -8.52M |
| EBIT | -4.01M | -5.47M | -6.85M | -7.58M | -8.83M |
| EBITDA | -3.61M | -4.99M | -6.41M | -7.14M | -8.40M |
| EPS Basic | -2.17 | -6.17 | -9.00 | -12.71 | -15.91 |
| Normalized Basic EPS | -1.36 | -4.36 | -6.31 | -8.42 | -10.60 |
| EPS Diluted | -2.17 | -6.17 | -9.00 | -12.71 | -15.91 |
| Normalized Diluted EPS | -1.36 | -4.36 | -6.31 | -8.42 | -10.60 |
| Average Basic Shares Outstanding | 8.20M | 5.70M | 4.38M | 3.27M | 2.14M |
| Average Diluted Shares Outstanding | 8.20M | 5.70M | 4.38M | 3.27M | 2.14M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |